0001127602-17-003208.txt : 20170131
0001127602-17-003208.hdr.sgml : 20170131
20170131192139
ACCESSION NUMBER: 0001127602-17-003208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170130
FILED AS OF DATE: 20170131
DATE AS OF CHANGE: 20170131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meline David W
CENTRAL INDEX KEY: 0001444612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 17562659
MAIL ADDRESS:
STREET 1: 3M COMPANY
STREET 2: 3M OFFICE OF GENERAL COUNSEL
CITY: ST PAUL
STATE: MN
ZIP: 55144-1000
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-01-30
0000318154
AMGEN INC
AMGN
0001444612
Meline David W
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
EVP & CFO
Common Stock
2017-01-30
4
F
0
529
157.16
D
50690
D
These shares include the following RSUs granted under the Company's equity plans: 27,081 RSUs which vest in one installment of 13,540 on 8/1/2017 and one installment of 13,541 on 8/1/2018; 2,640 RSUs which vest in one installment of 1,300 on 1/30/2018 and one installment of 1/340 on 1/30/2019; and 4,477 RSUs which vest in two equal installments of 1,477 on 5/3/2018 and 5/3/2019 and one installment of 1,523 on 5/3/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 1,723 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting persons' unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ David W. Meline
2017-01-31